drugset / Trial / NCT00649350
Food Study Metformin Hydrochloride ER Tablets 750 mg and Glucophage XR 750 mg
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to investigate the bioequivalence of Mylan's metformin hydrochloride ER tablets to Bristol-Myers Squibb's Glucophage® XR tablets following a single, oral 750 mg (1 x 750 mg) dose administered under fed conditions.
Timeline
- Start
- 2003-12
- Primary completion
- 2003-12
- Completion
- 2003-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 750 mg | Oral |
Indications
No indication recorded.